应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
XENE Xenon制药
盘后交易 05-15 16:00:20 EDT
40.45
-0.13
-0.32%
盘后
40.45
+0.00
0.00%
16:00 EDT
最高
41.84
最低
40.16
成交量
32.92万
今开
41.08
昨收
40.58
日振幅
4.14%
总市值
30.52亿
流通市值
28.15亿
总股本
7,546万
成交额
1,344万
换手率
0.47%
流通股本
6,960万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
花旗:维持Xenon Pharmaceuticals(XENE.US)评级,由买入调整至买入评级, 目标价由62.00美元调整至60.00美元。
智通财经 · 05-11
花旗:维持Xenon Pharmaceuticals(XENE.US)评级,由买入调整至买入评级, 目标价由62.00美元调整至60.00美元。
Xenon制药盘中异动 早盘股价大跌6.86%
自选股智能写手 · 05-10
Xenon制药盘中异动 早盘股价大跌6.86%
Wedbush:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。
智通财经 · 05-10
Wedbush:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。
暂无数据
公司概况
公司名称:
Xenon制药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Xenon Pharmaceuticals Inc.依据商业公司法(不列颠哥伦比亚省)在其前身(Xenon Bioresearch Inc.)名义下于1996年11月5日在不列颠哥伦比亚省注册成立。该公司是一家为孤儿发现和开发分化疗法管道的临床阶段生物制药公司,该公司打算为了更大的市场使自身商业化,并打算与全球制药公司建立合作伙伴。为了开发对症药物该公司通过研究罕见的具有极端特质的人类疾病,包括离子通道突变引发的疾病,又称为离子通道基因突变疾病建立了一个核心启用发现平台。公司拥有一个集成的平台,包括人类遗传学,小分子药物发现和临床前和临床开发等内部功能。
发行价格:
--
{"stockData":{"symbol":"XENE","market":"US","secType":"STK","nameCN":"Xenon制药","latestPrice":40.45,"timestamp":1715803199999,"preClose":40.58,"halted":0,"volume":329159,"hourTrading":{"tag":"盘后","latestPrice":40.45,"preClose":40.45,"latestTime":"16:00 EDT","volume":11507,"amount":465458.15,"timestamp":1715803207663},"delay":0,"floatShares":69601809,"shares":75463489,"eps":-2.502249,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.13,"latestTime":"05-15 16:00:20 EDT","open":41.08,"high":41.84,"low":40.158,"amount":13442461.860790001,"amplitude":0.041449,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.502249,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1715817600000},"adr":0,"listingDate":1415163600000,"adjPreClose":40.58,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":40.45,"preClose":40.45,"latestTime":"16:00 EDT","volume":11507,"amount":465458.15,"timestamp":1715803207663},"volumeRatio":1.142768},"requestUrl":"/m/hq/s/XENE/tweets","defaultTab":"tweets","newsList":[{"id":"2434897635","title":"花旗:维持Xenon Pharmaceuticals(XENE.US)评级,由买入调整至买入评级, 目标价由62.00美元调整至60.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434897635","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434897635?lang=zh_cn&edition=full","pubTime":"2024-05-11 05:45","pubTimestamp":1715377502,"startTime":"0","endTime":"0","summary":"花旗:维持Xenon Pharmaceuticals(XENE.US)评级,由买入调整至买入评级, 目标价由62.00美元调整至60.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110545068af27159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110545068af27159&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434854677","title":"Xenon制药盘中异动 早盘股价大跌6.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434854677","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434854677?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:31","pubTimestamp":1715347896,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时31分,Xenon制药股票出现异动,股价急速跳水6.86%。截至发稿,该股报39.58美元/股,成交量5703股,换手率0.01%,振幅0.89%。Xenon制药股票所在的生物技术行业中,整体涨幅为0.15%。Xenon制药公司简介:Xenon Pharmaceuticals Inc 是一家临床阶段的生物制药公司,致力于开发治疗方法,以改善神经系统疾病患者的生活,包括罕见的中枢神经系统疾病。该信息摘要如下:Wedbush:维持Xenon Pharmaceuticals评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510213136792706bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510213136792706bc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434674854","title":"Wedbush:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434674854","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434674854?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:26","pubTimestamp":1715347607,"startTime":"0","endTime":"0","summary":"Wedbush:维持Xenon Pharmaceuticals(XENE.US)评级,由优于大市调整至优于大市评级, 目标价由51.00美元调整至50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102126538750f2d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102126538750f2d6&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xenon-pharma.com","stockEarnings":[{"period":"1week","weight":-0.0656},{"period":"1month","weight":-0.0174},{"period":"3month","weight":-0.1633},{"period":"6month","weight":0.4139},{"period":"1year","weight":-0.0278},{"period":"ytd","weight":-0.119}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0244},{"period":"3month","weight":0.0496},{"period":"6month","weight":0.1623},{"period":"1year","weight":0.267},{"period":"ytd","weight":0.101}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xenon Pharmaceuticals Inc.依据商业公司法(不列颠哥伦比亚省)在其前身(Xenon Bioresearch Inc.)名义下于1996年11月5日在不列颠哥伦比亚省注册成立。该公司是一家为孤儿发现和开发分化疗法管道的临床阶段生物制药公司,该公司打算为了更大的市场使自身商业化,并打算与全球制药公司建立合作伙伴。为了开发对症药物该公司通过研究罕见的具有极端特质的人类疾病,包括离子通道突变引发的疾病,又称为离子通道基因突变疾病建立了一个核心启用发现平台。公司拥有一个集成的平台,包括人类遗传学,小分子药物发现和临床前和临床开发等内部功能。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.016498},{"month":2,"riseRate":0.8,"avgChangeRate":0.093266},{"month":3,"riseRate":0.2,"avgChangeRate":-0.073532},{"month":4,"riseRate":0.5,"avgChangeRate":0.011324},{"month":5,"riseRate":0.4,"avgChangeRate":-0.010507},{"month":6,"riseRate":0.333333,"avgChangeRate":0.027346},{"month":7,"riseRate":0.333333,"avgChangeRate":0.014281},{"month":8,"riseRate":0.777778,"avgChangeRate":0.069179},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.073402},{"month":10,"riseRate":0.333333,"avgChangeRate":0.057348},{"month":11,"riseRate":0.666667,"avgChangeRate":0.050085},{"month":12,"riseRate":0.7,"avgChangeRate":0.115516}],"exchange":"NASDAQ","name":"Xenon制药","nameEN":"Xenon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xenon制药(XENE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xenon制药(XENE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xenon制药,XENE,Xenon制药股票,Xenon制药股票老虎,Xenon制药股票老虎国际,Xenon制药行情,Xenon制药股票行情,Xenon制药股价,Xenon制药股市,Xenon制药股票价格,Xenon制药股票交易,Xenon制药股票购买,Xenon制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xenon制药(XENE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xenon制药(XENE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}